Sentry Investment Management’s Abiomed Inc ABMD Stock Holding History
Bought
Maintained
Sold
Other funds holding ABMD
TRSOTSOK
BTI
IA
AW
HNB
Sentry Investment Management's ABMD Position: Q4 2022 in Review
Sentry Investment Management sold out of Abiomed Inc (ABMD) in Q4 2022, closing a stake of 457 shares — an estimated $112K sold.
Sentry Investment Management first reported a position in ABMD in Q2 2014 and held it in 19 quarters. The position peaked at $1.23M in Q3 2018. 8 funds tracked by Wall St. Rank hold ABMD as of Q4 2022.
- Sentry Investment Management reported no remaining Abiomed Inc position as of Q4 2022 after selling out during the quarter.
- Sentry Investment Management sold 457 Abiomed Inc shares in Q4 2022, an estimated $112K.
- Sentry Investment Management first reported a position in Abiomed Inc in Q2 2014 and held it in 19 quarters.
- Sentry Investment Management's Abiomed Inc position peaked at $1.23M in Q3 2018.
- 8 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2022.
Based on Sentry Investment Management's 13F filing for Q4 2022, filed 8 Feb 2023.